Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Address: Yenişehir Mah. Özgür Sokak 16, Ataşehir/ Istanbul,Turkey
Tel: 0216 456 65 70
Web: http://www.berkoilac.com.tr/default.aspx
BERKO PHARMACEUTICALS initiallystarted its operations under the name of BERAN LABORATORY in Diyarbakır.A few years later, in 1984, BERKO PHARMACEUTICALS was founded inIstanbul. BERKO PHARMACEUTICALS, which initially produced a galenicpreparation, soon started to manufacture therapeutic medicines in itsown production facility.
In the early 2000’s, BERKOPHARMACEUTICALS started licensing new pharmaceuticals needed in Turkey.Consequently, various forms of zinc-containing ZINCO-branded productswere offered for the benefit of Turkish Medicine. Around that time, anagency agreement was signed with the Italian GANASSINI company, andsubsequently the importation and distribution of the Ear-Nose-Throatspecific medicines, TONIMER line, were initiated.
BERKOPHARMACEUTICALS founded its own production facilities early in 2004,and has come to produce a wide product range of ground breakingmedicine, all of which, with the exceptions of a few imports, itproduces itself in its own modern production facilities. BERKOPHARMACEUTICALS continues to offer both new and existing high-demandedbrands to the pediatric market.
BERKO PHARMACEUTICALS’ new high-tech facility started production in 2009.
BERKOPHARMACEUTICALS’ new production facility in Sultanbeyli, Istanbul, isdesigned to produce licensed medicines under the supervision of theMinistry of Health, Republic of Turkey. The 5000 m2 indoor facility wasdesigned in accordance with all relevant GMP requirements. Both thebuilding and the inner equipment -machine park and laboratory- of thisfactory were constructed by the latest technology.
Our liquidmanufacturing capacity under normal working conditions is 6,500,000boxes per year for syrups; 6,500,000 boxes per year for drops; and8,000,000 boxes per year for solid medicines.
BERKO PHARMACEUTICALS aims to manufacture only products that will always be in demand, while continuing to break new grounds.
Aftasol solution
Berko-Fiz Nasal Drops
ACD3 drops
Alores Syrup
Caillou Fish
Dencol Gel Spray
FerroZinc Syrup
Folas Drop…
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here